Distinct expression of Tim-3 during different stages of rat experimental autoimmune neuritis

Brain Research Bulletin

Volumn 86, Issue 3-4, 2011, Pages 229-234

  Zhang, Zhi Yuan ^a   Schluesener, Hermann J ^a   Zhang, Zhiren ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CD163; Experimental autoimmune neuritis; M2 macrophage; Tim 3

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BRAIN NERVE CELL; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL AUTOIMMUNE NEURITIS; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MACROPHAGE ACTIVATION; MALE; NEURITIS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; RAT; SCIATIC NERVE;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BEHAVIOR, ANIMAL; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; RATS; RATS, INBRED LEW; RECEPTORS, CELL SURFACE; SCIATIC NERVE;

EID: 80053251952     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.07.005     Document Type: Article

References (22)

1. Badylak S.F., Valentin J.E., Ravindra A.K., McCabe G.P., Stewart-Akers A.M. Macrophage phenotype as a determinant of biologic scaffold remodelling. Tissue Eng. A 2008, 14:1835-1842.
2. Frisancho-Kiss S., Coronado M.J., Frisancho J.A., Lau V.M., Rose N.R., Klein S.L., Fairweather D. Gonadectomy of male BALB/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav. Immun. 2009, 23:649-657.
3. Gold R., Hartung H.P., Toyka K.V. Animal models for autoimmune demyelinating disorders of the nervous system. Mol. Med. Today 2000, 6:88-91.
4. Kearley J., McMillan S.J., Lloyd C.M. Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo. J. Exp. Med. 2007, 204:1289-1294.
5. Kieseier B.C., Kiefer R., Gold R., Hemmer B., Willison H.J., Hartung H.P. Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 2004, 30:131-156.
6. Kuchroo V.K., Umetsu D.T., DeKruyff R.H., Freeman G.J. The TIM gene family: emerging roles in immunity and disease. Nat. Rev. Immunol. 2003, 3:454-462.
7. Li X., Chen G., Li Y., Wang R., Wang L., Lin Z., Gao X., Feng J., Ma Y., Shen B., Li Y., Han G. Involvement of T cell Ig Mucin-3 (Tim-3) in the negative regulation of inflammatory bowel disease. Clin. Immunol. 2010, 134:169-177.
8. Monney L., Sabatos C.A., Gaglia J.L., Ryu A., Waldner H., Chernova T., Manning S., Greenfield E.A., Coyle A.J., Sobel R.A., Freeman G.J., Kuchroo V.K. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002, 415:536-541.
9. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
10. Nakayama M., Akiba H., Takeda K., Kojima Y., Hashiguchi M., Azuma M., Yagita H., Okumura K. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood 2009, 113:3821-3830.
11. Oikawa T., Kamimura Y., Akiba H., Yagita H., Okumura K., Takahashi H., Zeniya M., Tajiri H., Azuma M. Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease. J. Immunol. 2006, 177:4281-4287.
12. Ricardo S.D., van Goor H., Eddy A.A. Macrophage diversity in renal injury and repair. J. Clin. Invest. 2008, 118:3522-3530.
13. Sabatos C.A., Chakravarti S., Cha E., Schubart A., Sánchez-Fueyo A., Zheng X.X., Coyle A.J., Strom T.B., Freeman G.J., Kuchroo V.K. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat. Immunol. 2003, 4:102-1110.
14. Sánchez-Fueyo A., Tian J., Picarella D., Domenig C., Zheng X.X., Sabatos C.A., Manlongat N., Bender O., Kamradt T., Kuchroo V.K., Gutiérrez-Ramos J.C., Coyle A.J., Strom T.B. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 2003, 4:1093-1101.
15. Schroll A., Eller K., Huber J.M., Theurl I.M., Wolf A.M., Weiss G., Rosenkranz A.R. Tim3 is upregulated and protective in nephrotoxic serum nephritis. Am. J. Pathol. 2010, 176:1716-1724.
16. Su E.W., Lin J.Y., Kane L.P. TIM-1 and TIM-3 proteins in immune regulation. Cytokine 2008, 44:9-13.
17. Van Gorp H., Delputte P.L., Nauwynck H.J. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. Mol. Immunol. 2010, 47:1650-1660.
18. Vandooren B., Noordenbos T., Ambarus C., Krausz S., Cantaert T., Yeremenko N., Boumans M., Lutter R., Tak P.P., Baeten D. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis Rheum. 2009, 60:966-975.
19. Zhang Z.Y., Zhang Z., Fauser U., Schluesener H.J. Expression of interleukin-16 in sciatic nerves, spinal roots and spinal cords of experimental autoimmune neuritis rats. Brain Pathol. 2009, 19:205-213.
20. Zhang Z., Zhang Z.Y., Schluesener H.J. Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects. J. Immunol. 2009, 183:3081-3091.
21. Zhang Z.Y., Zhang Z., Schluesener H.J. MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis. Neuroscience 2010, 169:370-377.
22. Zhu C., Anderson A.C., Schubart A., Xiong H., Imitola J., Khoury S.J., Zheng X.X., Strom T.B., Kuchroo V.K. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 2005, 6:1245-1252.